154 related articles for article (PubMed ID: 18839276)
1. Association of SNP in exon 1 of HBS1L with hemoglobin F level in beta0-thalassemia/hemoglobin E.
Pandit RA; Svasti S; Sripichai O; Munkongdee T; Triwitayakorn K; Winichagoon P; Fucharoen S; Peerapittayamongkol C
Int J Hematol; 2008 Nov; 88(4):357-361. PubMed ID: 18839276
[TBL] [Abstract][Full Text] [Related]
2. Variability of hemoglobin F expression in hemoglobin EE disease: hematological and molecular analysis.
Pakdee N; Yamsri S; Fucharoen G; Sanchaisuriya K; Pissard S; Fucharoen S
Blood Cells Mol Dis; 2014; 53(1-2):11-5. PubMed ID: 24581976
[TBL] [Abstract][Full Text] [Related]
3. Genetic Variants at BCL11A and HBS1L-MYB loci Influence Hb F Levels in Chinese Zhuang β-Thalassemia Intermedia Patients.
Lai Y; Chen Y; Chen B; Zheng H; Yi S; Li G; Wei H; He S; Zheng C
Hemoglobin; 2016 Nov; 40(6):405-410. PubMed ID: 28361591
[TBL] [Abstract][Full Text] [Related]
4. A Multi-locus Approach to Characterization of Major Quantitative Trait Loci Influencing Hb F Regulation in Chinese β-thalassemia Carriers.
Chan NC; Lau KM; Cheng KC; Chan NP; Ng MH
Hemoglobin; 2016 Nov; 40(6):400-404. PubMed ID: 27707011
[TBL] [Abstract][Full Text] [Related]
5. Modifying effect of XmnI, BCL11A, and HBS1L-MYB on clinical appearances: A study on β-thalassemia and hemoglobin E/β-thalassemia patients in Indonesia.
Rujito L; Basalamah M; Siswandari W; Setyono J; Wulandari G; Mulatsih S; Sofro AS; Sadewa AH; Sutaryo S
Hematol Oncol Stem Cell Ther; 2016 Jun; 9(2):55-63. PubMed ID: 27009595
[TBL] [Abstract][Full Text] [Related]
6. Polymorphic variations influencing fetal hemoglobin levels: association study in beta-thalassemia carriers and in normal individuals of Portuguese origin.
Pereira C; Relvas L; Bento C; Abade A; Ribeiro ML; Manco L
Blood Cells Mol Dis; 2015 Apr; 54(4):315-20. PubMed ID: 25842369
[TBL] [Abstract][Full Text] [Related]
7. Quantitative Trait Loci Influencing Hb F Levels in Southern Thai Hb E (HBB: c.79G>A) Heterozygotes.
Kesornsit A; Jeenduang N; Horpet D; Plyduang T; Nuinoon M
Hemoglobin; 2018 Jan; 42(1):23-29. PubMed ID: 29457528
[TBL] [Abstract][Full Text] [Related]
8. Implication of globin gene expression, hemoglobin F and hemoglobin E levels on β-thalassemia/Hb E disease severity.
Siriworadechkul S; Jindadamrongwech S; Chuncharunee S; Aupparakkitanon S
Ann Clin Lab Sci; 2014; 44(4):437-42. PubMed ID: 25361929
[TBL] [Abstract][Full Text] [Related]
9. The XmnI (G)gamma polymorphism influences hemoglobin F synthesis contrary to BCL11A and HBS1L-MYB SNPs in a cohort of 57 beta-thalassemia intermedia patients.
Nguyen TK; Joly P; Bardel C; Moulsma M; Bonello-Palot N; Francina A
Blood Cells Mol Dis; 2010 Aug; 45(2):124-7. PubMed ID: 20472475
[TBL] [Abstract][Full Text] [Related]
10. Annotated definition of BCL11A and HMIP-2 haplotypes through the analysis of sicilian β-thalassemia patients with high levels of fetal hemoglobin.
Buccheri MA; Spina S; Ruberto C; Lombardo T; Labie D; Ragusa AA
Hemoglobin; 2013; 37(5):423-34. PubMed ID: 23777413
[TBL] [Abstract][Full Text] [Related]
11. GENETIC FACTORS INFLUENCING HEMOGLOBIN F LEVEL IN β-THALASSEMIA/HB E DISEASE.
Ruangrai W; Jindadamrongwech S
Southeast Asian J Trop Med Public Health; 2016 Jan; 47(1):84-91. PubMed ID: 27086429
[TBL] [Abstract][Full Text] [Related]
12. The correlation of α-globin gene mutations and the XmnI polymorphism with clinical severity of Hb E/β-thalassemia.
Charoenkwan P; Teerachaimahit P; Sanguansermsri T
Hemoglobin; 2014; 38(5):335-8. PubMed ID: 25238043
[TBL] [Abstract][Full Text] [Related]
13. Genetic Modifiers in β-Thalassemia Intermedia: A Study on 102 Iraqi Arab Patients.
Al-Allawi NA; Puehringer H; Raheem RA; Oberkanins C
Genet Test Mol Biomarkers; 2015 May; 19(5):242-7. PubMed ID: 25751242
[TBL] [Abstract][Full Text] [Related]
14. Existence of HbF Enhancer Haplotypes at
Cyrus C; Vatte C; Borgio JF; Al-Rubaish A; Chathoth S; Nasserullah ZA; Jarrash SA; Sulaiman A; Qutub H; Alsaleem H; Alzahrani AJ; Steinberg MH; Ali AK
Biomed Res Int; 2017; 2017():1972429. PubMed ID: 28280727
[No Abstract] [Full Text] [Related]
15. Genetic Modifiers of Sickle Cell Disease: A Genotype-Phenotype Relationship Study in a Cohort of 82 Children on Mayotte Island.
Muszlak M; Pissard S; Badens C; Chamouine A; Maillard O; Thuret I
Hemoglobin; 2015; 39(3):156-61. PubMed ID: 25806420
[TBL] [Abstract][Full Text] [Related]
16. The Impact of XmnI-HBG2, BCL11A and HBS1L-MYB Single Nucleotide Polymorphisms on Hb F Variation of Hematologically Normal Iranian Individuals.
Keyhani E; Jafari Vesiehsari M; Talebi Kakroodi S; Darabi E; Zamani F; Karimlou M; Kamali K; Neishabury M
Hemoglobin; 2016 Jun; 40(3):198-201. PubMed ID: 27117569
[TBL] [Abstract][Full Text] [Related]
17. Hemoglobin F and hemoglobin E/beta-thalassemia.
Rees DC
J Pediatr Hematol Oncol; 2000; 22(6):567-72. PubMed ID: 11132232
[TBL] [Abstract][Full Text] [Related]
18. Molecular Understanding of Non-Transfusion-Dependent Thalassemia Associated with Hemoglobin E-β-Thalassemia in Northeast Thailand.
Yamsri S; Pakdee N; Fucharoen G; Sanchaisuriya K; Fucharoen S
Acta Haematol; 2016; 136(4):233-239. PubMed ID: 27710960
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Five Single Nucleotide Polymorphisms on Hb F Variation of β-Thalassemia Traits and Hematologically Normal Individuals in Southeast Turkey.
Genc A; Tastemir Korkmaz D; Bayram S; Rencuzogullari E
Hemoglobin; 2020 Jul; 44(4):231-239. PubMed ID: 32674697
[TBL] [Abstract][Full Text] [Related]
20. Beta-globin gene cluster polymorphisms are strongly associated with severity of HbE/beta(0)-thalassemia.
Ma Q; Abel K; Sripichai O; Whitacre J; Angkachatchai V; Makarasara W; Winichagoon P; Fucharoen S; Braun A; Farrer LA
Clin Genet; 2007 Dec; 72(6):497-505. PubMed ID: 17894837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
